2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Cugene Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus CUG252, Placebo - Systemic Lupus Erythematosus, SLE (Systemic Lupus) | Phase 1 | Completed | Cugene Inc. | 40 | 2023-04-24 | 2026-06-24 |
| A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers CUG252, Placebo - Systemic Lupus Erythematosus | Phase 1 | Completed | Cugene Inc. | 32 | 2021-11-09 | 2025-02-20 |
Lupus Erythematosus, Systemic (2)
United States (2)